Matches in Wikidata for { <http://www.wikidata.org/entity/Q65376238> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q65376238 description "clinical trial" @default.
- Q65376238 description "ensayu clínicu" @default.
- Q65376238 description "klinisch onderzoek" @default.
- Q65376238 description "клінічне випробування" @default.
- Q65376238 name "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 name "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 type Item @default.
- Q65376238 label "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 label "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 prefLabel "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 prefLabel "Saxagliptin Triple Oral Therapy" @default.
- Q65376238 P1132 Q65376238-825C57AC-3D1D-4908-BD85-5A1658F293E6 @default.
- Q65376238 P1476 Q65376238-2A9EEC8E-BFFB-4E0B-9D23-325BEA1EDC40 @default.
- Q65376238 P17 Q65376238-466EEE2E-E50B-45E4-B15C-D854DF67DBF2 @default.
- Q65376238 P17 Q65376238-6EA41083-594C-459A-923C-84FE5CCE7372 @default.
- Q65376238 P17 Q65376238-9DAD187C-8816-449A-9CE0-5A890D37E8DC @default.
- Q65376238 P17 Q65376238-CBE07410-AF70-4437-BD62-BBE6A233F794 @default.
- Q65376238 P17 Q65376238-F9627914-B247-450B-A036-5223798AF200 @default.
- Q65376238 P2899 Q65376238-AE3D2310-FE8C-467C-9FFB-08BBA4336DC5 @default.
- Q65376238 P3098 Q65376238-1E15C277-D8C8-42C4-9751-A2BFF4709FE4 @default.
- Q65376238 P31 Q65376238-4121A80C-4DC4-4A14-A981-79BC47A43A9C @default.
- Q65376238 P4844 Q65376238-D82C5FF3-D069-448B-8F6E-02D092DCDA2D @default.
- Q65376238 P580 Q65376238-077EA24E-A313-40C1-86BB-2E875833F6C2 @default.
- Q65376238 P582 Q65376238-A9D3E632-4FF9-4A4F-AC6E-4F7480CFB0E2 @default.
- Q65376238 P6099 Q65376238-1DF2C138-0F7C-45BC-BCA8-0577F4366836 @default.
- Q65376238 P767 Q65376238-4196D76B-72AB-4060-B7D4-EB01E75E393F @default.
- Q65376238 P8363 Q65376238-95BBC01A-5742-4217-BA8B-643196212FF3 @default.
- Q65376238 P1132 "+257" @default.
- Q65376238 P1476 "A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study to Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin and Sulfonylurea in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Combination of Metformin and Sulfonylurea" @default.
- Q65376238 P17 Q145 @default.
- Q65376238 P17 Q16 @default.
- Q65376238 P17 Q408 @default.
- Q65376238 P17 Q668 @default.
- Q65376238 P17 Q869 @default.
- Q65376238 P2899 "+18" @default.
- Q65376238 P3098 "NCT01128153" @default.
- Q65376238 P31 Q30612 @default.
- Q65376238 P4844 Q19484 @default.
- Q65376238 P580 "2010-06-01T00:00:00Z" @default.
- Q65376238 P582 "2011-06-01T00:00:00Z" @default.
- Q65376238 P6099 Q42824827 @default.
- Q65376238 P767 Q266423 @default.
- Q65376238 P8363 Q78089383 @default.